Silo Pharma, Inc.
SILO Nasdaq
SEC CIK 1514183
Follow Silo Pharma
Weekly email: filings, results, news
Revenue, last quarter
$0
−100% vs same quarter last year
Net income
−$832.8K
+30.8% vs same quarter last year
EPS, diluted
−$0.76
+73.6% vs same quarter last year
Operating cash flow
−$781.9K
+39.2% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $72.1K | −$4.2M |
| FY24 | $72.1K | −$4.4M |
| FY23 | $72.1K | −$3.7M |
| FY22 | $72.1K | −$3.9M |
| FY21 | - | $3.9M |
| FY20 | $40.9K | −$3M |
| FY19 | $40.6K | −$1M |
| FY18 | - | −$969.5K |
| FY17 | - | $356.5K |
| FY16 | - | - |
| FY13 | - | - |
| FY12 | - | −$39.4K |
| FY11 | - | −$49.8K |
| FY10 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 38.6% | −5937% | −5863.5% |
| FY24 | 91.9% | −6526.4% | −6092.6% |
| FY23 | 91.9% | −5347.4% | −5132.6% |
| FY22 | 91.9% | −5031.3% | −5420.9% |
| FY21 | - | - | - |
| FY20 | −330.4% | −5380.2% | −7422.5% |
| FY19 | 32.5% | −2293.4% | −2497.7% |
| FY18 | - | - | - |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
| FY11 | - | - | - |
| FY10 | - | - | - |
- Silo Pharma
- Healthcare median
Show the numbers
| Year | Silo Pharma | Healthcare median |
|---|---|---|
| FY25 | −5863.5% | −40.6% |
| FY24 | −6092.6% | −60.7% |
| FY23 | −5132.6% | −97.1% |
| FY22 | −5420.9% | −128.5% |
| FY21 | - | −129.2% |
| FY20 | −7422.5% | −136.5% |
| FY19 | −2497.7% | −133.7% |
| FY18 | - | −173.4% |
| FY17 | - | −176.7% |
| FY16 | - | −164.8% |
| FY13 | - | −88.5% |
| FY12 | - | −87.4% |
| FY11 | - | −76.3% |
| FY10 | - | - |
News
No stories filed under Silo Pharma yet - coverage appears here as the news feed clusters it.